Efficacy of synbiotic, probiotic, and prebiotic treatments for irritable bowel syndrome in children: A randomized controlled trial

Basturk A., ARTAN R., YILMAZ A.

TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.27, sa.5, ss.439-443, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 27 Sayı: 5
  • Basım Tarihi: 2016
  • Doi Numarası: 10.5152/tjg.2016.16301
  • Dergi Adı: TURKISH JOURNAL OF GASTROENTEROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.439-443
  • Anahtar Kelimeler: Bifidobacterium lactis B94, irritable bowel syndrome, synbiotic, probiotic, child, PLACEBO-CONTROLLED-TRIAL, B94 PLUS INULIN, CLINICAL-TRIAL, DOUBLE-BLIND, FECAL MICROBIOTA, FERMENTED MILK, SYMPTOMS, BIFIDOBACTERIUM, DIARRHEA, TRANSIT
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Background/Aims: Irritable bowel syndrome (IBS) is an important health problem that presents serious social burdens and high costs. Our study investigated the efficacy of synbiotic (Bifidobacterium lactis B94 with inulin), probiotic (B. lactis B94), and prebiotic (inulin) treatment for IBS in a pediatric age group.